In:
JCO Precision Oncology, American Society of Clinical Oncology (ASCO), , No. 7 ( 2023-08)
Abstract:
Only 20% of noncanonical primary tumors from germline BRCA1/2 carriers have homologous recombination deficiency.
Type of Medium:
Online Resource
ISSN:
2473-4284
Language:
English
Publisher:
American Society of Clinical Oncology (ASCO)
Publication Date:
2023
Permalink